Patentret

Plesner råder over Danmarks største og stærkeste hold af patentretsadvokater. Vores patentretlige erfaring, tilgængelighed, forretningsmæssige indsigt og evne til at forstå og udfordre den involverede teknologi sætter os i stand til at give den bedste, patentretlige rådgivning i Danmark.

Vi rådgiver om og fører hvert år et betydeligt antal sager om patentspørgsmål. Plesner repræsenterer en stor andel af originalproducenterne på medicinalområdet, herunder ni ud af ti af de største medicinalselskaber i verden.

Vores rådgivning om patentforhold dækker alle områder af patentretten og omfatter navnlig:

  • Sager om krænkelse og gyldighed af patenter, brugsmodeller og SPC'er
  • Sager om ejendomsretten til opfindelser, herunder arbejdstageres, forskeres og medopfinderes rettigheder
  • Bevissikringssager
  • Udfærdigelse og forhandling af aftaler, herunder forsknings- og udviklingsaftaler samt licensaftaler
  • IP-transaktioner
  • IP Risk Management
  • Strategisk optimering af globale håndhævelsesmuligheder
  • Den nye fælles EU patentdomstol 

De fleste af vores sager går på tværs af landegrænser, og vi arbejder derfor løbende sammen med førende, udenlandske patentretsrådgivere. Det giver os adgang til et internationalt netværk, som sætter os i stand til også at handle hurtigt uden for Danmarks grænser.

Ratings

  • Market-leading outfit offering long-standing experience and expertise across all areas of IP law. Highly regarded for its extensive experience in advising pharma originators on patent law. Strong trade mark practice trusted by high-profile clients. Its lawyers advise on prosecution, data protection and compliance issues.

    "This is a high-end, go-to firm for IP, with great attorneys."
    "Its lawyers have close knowledge of our procedures and portfolios, so we are able to act proactively on our matters."
     (2016)
  • Plesner sits comfortably at the apex of the Danish IP scene. It takes the lead on the vast majority of crucial patent suits on home soil – especially those with international relevance. It has practically cornered the market in terms of pharmaceutical originator work, with unmatched experience in clashes between innovators and generics. (2016)
  • Plesner has an award-winning IP practice. Market feedback suggests it is arguably the best firm for IP litigation in Denmark. "They’re in their own small league" one rival admits. In particular, the firm is often seen in the most complex pharmaceutical patent cases in the country. "Traditionally strong in all IP" says another commentator. (2016)
  • Plesner is listed in "Band 1" as regards Intellectual Property. (2016)
  • Plesner is Managing IP's Danish Firm of the Year. Its "stable" IP team, often seen in pharmaceutical patent disputes, is widely respected.

    "A top class firm in patent litigation in Denmark"

    "Plesner is the grand firm in IP litigation. They handle things very well and are consistent." (2015)

  • "Mighty" full-service firm Plesner continues its reign at the apex of the market. The darling of many pharmaceutical giants, it is the only Danish firm to count three specialist patent litigators among its ranks. As such, it attracts the lion’s share of contentious instructions and is "probably the only firm in a position to turn down work". (2015)
  • Plesner is listed in "Band 1" as regards Intellectual Property. (2015)
  • The firm’s IP practice is a powerhouse within every area of IP and advises and litigates on all IP law aspects such as patents, trademarks, copyrights, piracy and counterfeiting, designs, domains, consumer law, privacy policy law and marketing law. (2014)

  • Plesner's "highly knowledgeable" seven-partner group is recommended for copyright, design, patent and trade mark litigation. (2014)

  • "If there was a tier zero I would put Plesner in that as they are the best in the country for patent work,” says a colleague of the team at the full-service firm. Peers all agree that the team is "driving the work in this area". (2014)

Se flere Se færre

Vores partnere

Seneste nyt om Life Science og IP-ret

IP-ret